InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: Swordfishing post# 1758

Wednesday, 09/27/2017 2:39:13 PM

Wednesday, September 27, 2017 2:39:13 PM

Post# of 13874
Immune if Pharma partnering with Bristo-Myers for clinical trial study of Berilimumab drug treatment on bulliou pemphigoid. $150 million up front, 270 million in mile stones payment, $15 a share after FDA approval.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.